Drug Price Trends for NDC 00143-9144

Average Pharmacy Cost for 00143-9144

Drug Name	NDC	Price/Unit ($)	Unit	Date
LIRAGLUTIDE 2-PAK 18 MG/3 ML	00143-9144-02	67.21171	ML	2025-04-23
LIRAGLUTIDE 3-PAK 18 MG/3 ML	00143-9144-03	64.10884	ML	2025-04-23
LIRAGLUTIDE 2-PAK 18 MG/3 ML	00143-9144-02	68.05679	ML	2025-03-19
LIRAGLUTIDE 3-PAK 18 MG/3 ML	00143-9144-03	67.73556	ML	2025-03-19
LIRAGLUTIDE 2-PAK 18 MG/3 ML	00143-9144-02	69.78614	ML	2025-02-19
LIRAGLUTIDE 3-PAK 18 MG/3 ML	00143-9144-03	70.60535	ML	2025-02-19
LIRAGLUTIDE 2-PAK 18 MG/3 ML	00143-9144-02	71.93677	ML	2025-02-05

Best Wholesale Price for NDC 00143-9144

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Drug NDC: 00143-9144

The pharmaceutical industry is constantly evolving, with new drugs entering the market and existing ones facing price fluctuations. In this article, we'll dive deep into the market analysis and price projections for the drug identified by the National Drug Code (NDC) 00143-9144. Understanding the dynamics surrounding this specific drug can provide valuable insights for healthcare professionals, investors, and patients alike.

Understanding the National Drug Code (NDC)

Before we delve into the specifics of NDC 00143-9144, it's crucial to understand what an NDC represents. The National Drug Code is a unique, three-segment number assigned by the Food and Drug Administration (FDA) to human drugs in the United States[7]. This code serves as a universal product identifier for drugs, playing a vital role in their identification and tracking throughout the healthcare system.

Breaking Down NDC 00143-9144

Let's break down the components of our specific NDC:

• Labeler Code: 00143
• Product Code: 9144
• Package Code: Not specified in the given NDC

The labeler code identifies the manufacturer, while the product code specifies the strength, dosage form, and formulation of the drug. The package code, which is not provided in this case, would typically indicate the package size and type.

Identifying the Drug: Liraglutide Injection

Based on the available information, NDC 00143-9144 corresponds to Liraglutide Injection for subcutaneous use[8]. Liraglutide is a medication primarily used in the treatment of type 2 diabetes and, in some cases, for weight management.

"This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight."[8]

Market Analysis for Liraglutide

Current Market Position

Liraglutide, marketed under brand names like Victoza and Saxenda, has gained significant traction in the pharmaceutical market. Its dual application in diabetes management and weight loss has contributed to its growing popularity.

Market Trends Influencing Liraglutide

Several key trends are shaping the market for drugs like Liraglutide:

1. Rise of GLP-1 Receptor Agonists: Liraglutide belongs to the class of GLP-1 receptor agonists, which have seen a surge in demand due to their efficacy in managing diabetes and promoting weight loss[3].

2. Increasing Prevalence of Diabetes and Obesity: The global rise in diabetes and obesity rates is driving the demand for medications like Liraglutide[3].

3. Focus on Personalized Medicine: The trend towards personalized treatments based on factors like genetics and behavior could impact the prescription patterns of Liraglutide[6].

4. Advancements in Drug Delivery: Innovations in drug delivery systems could potentially enhance the efficacy and convenience of Liraglutide administration[3].

Competitive Landscape

To understand the market position of Liraglutide, it's essential to consider its competitors:

1. Other GLP-1 Receptor Agonists: Drugs like semaglutide (Ozempic, Wegovy) and dulaglutide (Trulicity) compete directly with Liraglutide.

2. DPP-4 Inhibitors: Medications like sitagliptin (Januvia) and linagliptin (Tradjenta) offer alternative diabetes management options.

3. SGLT2 Inhibitors: Drugs such as empagliflozin (Jardiance) and dapagliflozin (Farxiga) provide competition in the diabetes treatment space.

Factors Influencing Price Projections

Several factors will likely impact the future pricing of Liraglutide:

1. Regulatory Environment

The pharmaceutical industry is bracing for potential changes in the regulatory landscape. The BIOSECURE ACT in the United States and the potential return of Donald Trump as president in 2025 could significantly impact drug pricing policies[3].

2. Market Demand

The increasing prevalence of diabetes and obesity is likely to drive up demand for Liraglutide, potentially influencing its pricing[3].

3. Competition from Biosimilars

The emergence of biosimilars in the GLP-1 receptor agonist market could put downward pressure on Liraglutide prices[3].

4. Manufacturing and Supply Chain Factors

Efforts to enhance supply chain resilience and establish new manufacturing hubs could impact production costs and, consequently, pricing[3].

5. Research and Development Costs

Ongoing research into new indications or improved formulations of Liraglutide could influence its pricing structure.

Price Projections

While specific price projections for Liraglutide (NDC 00143-9144) are not available in the provided sources, we can make some informed estimates based on industry trends:

1. Short-term Outlook: Given the projected overall drug price inflation rate of 3.81% for 2025[2], it's reasonable to expect a similar increase for Liraglutide, barring any significant market disruptions.

2. Mid-term Projections: The entry of biosimilars and potential regulatory changes could lead to price moderation in the 3-5 year timeframe.

3. Long-term Forecast: Long-term pricing will likely depend on the drug's efficacy in new indications, competition from novel therapies, and broader healthcare policy changes.

Impact of Industry Trends on Liraglutide

Several broader industry trends could influence the market position and pricing of Liraglutide:

1. Shift Towards Value-Based Care

The industry-wide move towards value-based care could impact how Liraglutide is priced and reimbursed, potentially tying its cost more closely to patient outcomes[6].

2. Technological Advancements

The integration of AI and digital tools in pharmaceutical R&D could lead to more efficient drug development and production processes, potentially affecting pricing strategies[3].

3. Focus on Preventive Care

As the healthcare ecosystem shifts towards prevention and early intervention, drugs like Liraglutide that can help manage chronic conditions may see increased demand[6].

4. Personalized Medicine

The trend towards personalized treatments could lead to more targeted use of Liraglutide, potentially affecting its market size and pricing[6].

Strategies for Stakeholders

Given the market analysis and price projections, various stakeholders in the healthcare ecosystem should consider the following strategies:

For Healthcare Providers

1. Stay informed about the latest clinical data on Liraglutide's efficacy and safety.
2. Consider Liraglutide's place in treatment algorithms for diabetes and weight management.
3. Be prepared to discuss cost implications with patients, considering potential price changes.

For Patients

1. Discuss the cost-benefit ratio of Liraglutide with healthcare providers.
2. Stay informed about potential generic or biosimilar alternatives that may become available.
3. Explore patient assistance programs or insurance coverage options to manage costs.

For Payers

1. Monitor the evolving competitive landscape in the GLP-1 receptor agonist market.
2. Consider value-based contracting options for Liraglutide.
3. Evaluate the long-term cost-effectiveness of Liraglutide in managing diabetes and obesity.

For Manufacturers

1. Invest in research to expand Liraglutide's indications and improve its formulation.
2. Prepare for potential biosimilar competition by focusing on brand differentiation.
3. Explore innovative pricing models that align with value-based care principles.

Future Outlook

The future of Liraglutide (NDC 00143-9144) in the pharmaceutical market looks promising, albeit with some challenges. The drug's dual application in diabetes management and weight loss positions it well in a market with growing demand. However, potential regulatory changes, the entry of biosimilars, and the broader shift towards value-based care could reshape its market position and pricing structure.

As we look towards 2025 and beyond, the pharmaceutical industry is poised for significant transformations. The potential return of funding liquidity, advancements in drug delivery, and the rise of personalized medicine all present opportunities for drugs like Liraglutide to innovate and adapt[3].

Key Takeaways

• NDC 00143-9144 corresponds to Liraglutide Injection, a medication used for diabetes management and weight loss.
• The market for Liraglutide is influenced by factors such as the rising prevalence of diabetes and obesity, regulatory changes, and advancements in personalized medicine.
• Price projections suggest a potential short-term increase in line with overall drug price inflation, with mid to long-term pricing dependent on factors like biosimilar competition and regulatory changes.
• Stakeholders should stay informed about market trends, consider value-based approaches, and prepare for potential shifts in the competitive landscape.
• The future outlook for Liraglutide remains positive, but adaptability to market changes will be crucial for its continued success.

FAQs

1. Q: How might the potential return of Donald Trump as president in 2025 affect the pricing of drugs like Liraglutide? A: While specific impacts are uncertain, Trump's presidency could lead to changes in drug pricing policies, potentially affecting the pricing strategies for drugs like Liraglutide. It's important to monitor policy developments closely.

2. Q: What role does the National Drug Code (NDC) play in market analysis and price projections? A: The NDC serves as a unique identifier for drugs, allowing for accurate tracking and analysis of specific products in the market. This granular identification is crucial for precise market analysis and price projections.

3. Q: How might the emergence of biosimilars impact the market for Liraglutide? A: Biosimilars could introduce increased competition, potentially leading to price moderation for Liraglutide. However, factors such as brand loyalty and clinical differentiation could mitigate this impact.

4. Q: What impact could advancements in personalized medicine have on the use and pricing of Liraglutide? A: Personalized medicine could lead to more targeted use of Liraglutide, potentially affecting its market size. This could influence pricing strategies, possibly leading to more value-based pricing models.

5. Q: How might the shift towards value-based care affect the pricing and reimbursement of Liraglutide? A: Value-based care could lead to pricing and reimbursement models that are more closely tied to patient outcomes. This might result in more complex pricing structures that consider the drug's effectiveness in managing diabetes and promoting weight loss.

6. FDA.gov: National Drug Code Directory

7. Drugpatentwatch.com: Latest drug prices and trends for NDC 00143-9158

8. Pharmtech.com: Pharmapack Reports on Key Trends for 2025

9. Pwc.com: Pharma industry trends: PwC

10. FDA.gov: National Drug Code Database Background Information

11. Ndclist.com: NDC Package 0143-9144-02 Liraglutide Injection Subcutaneous